4//SEC Filing
Erlander Mark 4
Accession 0000950170-25-038694
CIK 0001213037other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:02 PM ET
Size
5.5 KB
Accession
0000950170-25-038694
Insider Transaction Report
Form 4
Erlander Mark
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2025-03-11+758,400→ 2,925,098 totalExercise: $3.58Exp: 2035-03-11→ Common Stock (758,400 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on March 11, 2026 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.
Documents
Issuer
Cardiff Oncology, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001651537
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:02 PM ET
- Size
- 5.5 KB